ストックスクリーナーアプリを入手
57.75
0.54%
0.31
アフターアワーズ：
56.89
-0.86
-1.49%
Halozyme Therapeutics Inc (HALO) 最新ニュース
Halozyme projects $1.15B-$1.225B revenue for 2025 with growth from key products - MSN
SEC Form 4 filed by PRESIDENT AND CEO Torley Helen - Quantisnow
Halozyme Therapeutics (HALO) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Benchmark Reaffirms "Buy" Rating for Halozyme Therapeutics (NASDAQ:HALO) - MarketBeat
Hussman Strategic Advisors Inc. Acquires 31,500 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
HALO's Q4 Earnings Beat, Higher Royalties Drive Revenue Growth - MSN
Meitav Investment House Ltd. Lowers Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Earnings Update: Halozyme Therapeutics, Inc. (NASDAQ:HALO) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts - Simply Wall St
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Handelsbanken Fonder AB - MarketBeat
Rhumbline Advisers Buys 5,833 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Assessing Halozyme Therapeutics: Insights From 9 Financial Analysts - Benzinga
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock - Yahoo Finance
HC Wainwright Forecasts Strong Price Appreciation for Halozyme Therapeutics (NASDAQ:HALO) Stock - MarketBeat
Halozyme Therapeutics Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Kestra Private Wealth Services LLC Sells 9,161 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Congress Asset Management Co. Cuts Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Call Transcript - Insider Monkey
Kornitzer Capital Management Inc. KS Has $10.19 Million Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Holdings Boosted by Convergence Investment Partners LLC - MarketBeat
Halozyme stock target raised to $78 at JMP Securities - Investing.com India
Halozyme stock target raised to $78 at JMP Securities By Investing.com - Investing.com Nigeria
Halozyme Therapeutics Inc (HALO) Q4 2024 Earnings Call Highlights: Record Revenue and Strong ... By GuruFocus - Investing.com Canada
Halozyme Therapeutics: Q4 Earnings Snapshot - CT Insider
Halozyme Therapeutics Inc (HALO) Q4 2024 Earnings Call Highlights: Record Revenue and Strong ... - Yahoo Finance
Halozyme Therapeutics (HALO) Q4 Earnings and Revenues Top Estimates - MSN
Halozyme Therapeutics Inc (HALO) Q4 Earnings: EPS of $1.06 Beats - GuruFocus.com
Halozyme Therapeutics Q4 2024 Earnings Preview - MSN
Halozyme Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Halozyme Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Halozyme shares surge 6% on strong Q4 results, upbeat 2025 outlook - Investing.com Nigeria
Earnings Flash (HALO) Halozyme Therapeutics Reports Q4 Adjusted EPS $1.26, vs. FactSet Est of $1.13 - Marketscreener.com
Halozyme Therapeutics Reiterates FY 2025 Guidance For EPS of $4.95-$5.35 on Revenue of $1.15-$1.225 Billion, vs FactSet Analyst Consensus of $4.90/Share on Revenue of $1.19 Billion - Marketscreener.com
Halozyme Therapeutics, Inc. Q4 Profit Increases, Beats Estimates - Nasdaq
HALOZYME REPORTS FULL YEAR 2024 RECORD REVENUE OF $1.015 BILLION AND EXCEEDS ITS FINANCIAL GUIDANCE FOR ROYALTY REVENUE, ADJUSTED EBITDA AND NON-GAAP DILUTED EPS - PR Newswire
Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast? - MSN
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock - Yahoo Finance
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today - MSN
HALO Gears Up to Report Q4 Earnings: Here's What You Should Know - MSN
Davidson Capital Management Inc. Grows Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
State of Alaska Department of Revenue Has $2.22 Million Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Shaker Investments LLC OH Raises Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Therapeutics (HALO) Projected to Post Earnings on Tuesday - MarketBeat
Halozyme rated overweight by Morgan Stanley, diversified revenue cited - MSN
Q1 EPS Estimate for Halozyme Therapeutics Lowered by Analyst - MarketBeat
Halozyme director Connie Matsui to exit board By Investing.com - Investing.com Canada
Halozyme director Connie Matsui to exit board - Investing.com
Halozyme Board Member Connie Matsui Steps Down - TipRanks
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by WCM Investment Management LLC - MarketBeat
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):